BHR Biosynex has announced an exclusive UK distribution agreement with Hunan Ehome Health Technology Company Limited for the EHBT-50 Minilab Multi-Functional Analyser, an all-in-one diagnostic platform that brings together haematology, immunology, biochemistry, urine and faecal testing in a single compact device.
For healthcare professionals, the EHBT-50 enables faster, more efficient and cost-effective workflows across hospitals, laboratories, GP practices and community settings. For patients, it translates into quicker access to accurate results, earlier diagnosis, timely treatment decisions and smoother care pathways – helping to improve both outcomes and overall healthcare system efficiency.
BHR Biosynex is pleased to confirm that the EHBT-50 will launch in the UK with a fully validated NHS Hospital Protocol Template to support clinical adoption.
Wendy Thompson, Head of Marketing at BHR Biosynex, commented: “We are thrilled to bring the EHBT-50 Minilab to the UK healthcare market. This innovative analyser represents a major step forward in point-of-care diagnostics, offering clinicians a versatile, accurate and space-saving solution while improving the patient experience. At BHR Biosynex, we are committed to supporting UK healthcare professionals with the very best technology, and the EHBT-50 is a clear example of that commitment.”
BHR Biosynex looks forward to showcasing the analyser on Stand 900 at the IBMS Congress in Birmingham, 22-25 September 2025, where healthcare professionals will be able to see live demonstrations and explore the system’s capabilities first-hand.
Web: www.bhr.co.uk
